Unichem Labs Gets Us Fda Marketing Approval For Generic Celebrex Capsules
Unichem Laboratories Limited Has Announced That It Has Received Anda Approval For Its Celecoxib Capsules, 50 Mg, 100 Mg, 200 Mg, And 400 Mg From The United States Food And Drug Administration (Fda) To Market A Generic Version Of Celebrex (Celecoxib) Capsules Of G.D. Searle Llc, Division Of Pfizer Inc.Celecoxib Capsules Are Indicated For Treatment Of Osteoarthritis, Rheumatoid Arthritis Juvenile Rheumatoid Arthritis, Ankylosing Spondylitis, Acute Pain And Primary Dysmenorrhea.The Product Will Be Commercialized From Unichem'S Goa Plant.Unichem Laboratories Limited Is An International, Integrated, Specialty Pharmaceutical Company. It Manufactures And Markets A Large Basket Of Pharmaceutical Formulations As Branded Generics As Well As Generics In Several Markets Across The World.
Let’s apply Data-Driven Pricing to Your APIs
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions!
Learn More!